Skip to content
    Kennedy Lewis Investment Management logo

    Kennedy Lewis Investment Management

    New York, New York, United StatesFounded 2017

    Kennedy Lewis Investment Management is a multi-strategy private credit platform specializing in non-sponsor lending and bespoke capital solutions for middle-market companies. Founded in 2017, the firm manages over $35 billion in assets and focuses on opportunistic credit strategies including event-driven situations.

    40% of their portfolio is in AI. They made 1 investment in the last 12 months. Their most common stage is series-c (40% of deals). Average disclosed round size is $74.5M (across 4 rounds with reported amounts).

    Find people at Kennedy Lewis Investment Management on Goldilocks AI

    Portfolio

    3

    Fund Size

    $4.1B

    Top Stage

    Series C

    Last 12 Mo

    1

    Team

    DL

    Darren Lewis Richman

    Co-Founder, Co-Portfolio Manager & Co-Managing Partner

    DK

    David Kennedy Chene

    Co-Founder, Co-Portfolio Manager & Co-Managing Partner

    DL

    Doug Logigian

    Co-Managing Partner & President

    AG

    Adam Goldberg

    Managing Director

    AP

    Adil Pasha

    Managing Director

    BK

    Brandon Karsch

    Managing Director, Co-Head of CLO Research

    BH

    Brett Herschenfeld

    Managing Director

    BN

    Brieanne Nikrandt

    Managing Director

    CG

    Craig Goldsmith

    Managing Director, Chief of Staff

    DM

    David Magid

    Managing Director

    EI

    Eric Im

    Managing Director, Co-Deputy CLO Portfolio Manager

    EK

    Eugene Koltunov

    Managing Director, Co-Deputy CLO Portfolio Manager

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    5 investments
    CompanyRoundAmountDate
    Onchilles Pharma logoOnchilles PharmaSeries A$25MNov 2025
    Sanctuary Wealth logoSanctuary WealthGrowth$175MJul 2022
    Clickatell logoClickatellSeries C$91MFeb 2022
    Clickatell logoClickatellSeries C—Jan 2022
    Onchilles Pharma logoOnchilles PharmaSeries A$7MJan 2021

    Top Co-Investors

    Last updated: 20 October 2026